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CRISPR‑based transcriptional 
activation tool for silent genes 
in filamentous fungi
László Mózsik1,6, Mirthe Hoekzema1,5,6, Niels A. W. de Kok1, Roel A. L. Bovenberg2,3, 
Yvonne Nygård1,2,4 & Arnold J. M. Driessen1*
Filamentous fungi are historically known to be a rich reservoir of bioactive compounds that are 
applied in a myriad of fields ranging from crop protection to medicine. The surge of genomic data 
available shows that fungi remain an excellent source for new pharmaceuticals. However, most 
of the responsible biosynthetic gene clusters are transcriptionally silent under laboratory growth 
conditions. Therefore, generic strategies for activation of these clusters are required. Here, we present 
a genome‑editing‑free, transcriptional regulation tool for filamentous fungi, based on the CRISPR 
activation (CRISPRa) methodology. Herein, a nuclease‑defective mutant of Cas9 (dCas9) was fused 
to a highly active tripartite activator VP64‑p65‑Rta (VPR) to allow for sgRNA directed targeted gene 
regulation. dCas9‑VPR was introduced, together with an easy to use sgRNA “plug‑and‑play” module, 
into a non‑integrative AMA1‑vector, which is compatible with several filamentous fungal species. To 
demonstrate its potential, this vector was used to transcriptionally activate a fluorescent reporter 
gene under the control of the penDE core promoter in Penicillium rubens. Subsequently, we activated 
the transcriptionally silent, native P. rubens macrophorin biosynthetic gene cluster by targeting 
dCas9‑VPR to the promoter region of the transcription factor macR. This resulted in the production 
of antimicrobial macrophorins. This CRISPRa technology can be used for the rapid and convenient 
activation of silent fungal biosynthetic gene clusters, and thereby aid in the identification of novel 
compounds such as antimicrobials.
Abbreviations
BGC  Biosynthetic gene cluster
CRISPRa  CRISPR activation
SM  Secondary metabolite
cDNA  Complementary DNA
sgRNA  Chimeric single guide RNA
RNPs  Ribonucleoprotein complexes
NLS  Nuclear localization signal
CP  Core promoter
TSS  Transcription start site
Fungi are amongst the most proliferous producers of secondary metabolites (SMs). These molecules, while not 
intrinsically required for survival, provide a biological advantage to their  host1. Many fungal SMs are beneficial 
to humankind and have a wide range of applications in human and animal healthcare (e.g. as antibiotics or 
immunosuppressants), food, agricultural and industrial  sectors2,3. On the other hand, SMs can be toxic and 
some SMs contribute to the pathogenicity of fungi while others contaminate food and  crops4. Genes involved 
in secondary metabolism are often arranged in clusters, so-called biosynthetic gene clusters (BGCs), and these 
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are typically regulated by pathway-specific transcription factors. As more fungal genomes, and bioinformatics 
tools and databases (e.g. fungal  antiSMASH5,  MIBiG6) have become available for the prediction, annotation 
and prioritization of fungal BGCs, it has become clear that filamentous fungi have an even larger biosynthetic 
potential than previously anticipated.
Most of the BGCs are transcriptionally silent under laboratory growth conditions, therefore products of 
these clusters remain  elusive7. Various methodologies have been developed for the activation of silent BGCs, 
including manipulation of both BGC specific as well as global transcriptional regulators, promoter-exchange, 
and heterologous expression in suitable host systems [reviewed  in8]. Marker-free genome editing remains chal-
lenging, and with only a limited number of fungal selection markers available, extensive genome manipulations 
is a laborious task.
The bacterial CRISPR/Cas systems have emerged as versatile biotechnological  tools9,10, and next to genome 
editing it can provide a promising alternative approach for transcriptional activation in fungi. CRISPR/Cas 
systems consist of only two components; a Cas nuclease and a programmable guide RNA. In case of the popular 
Cas9 system from Streptococcus pyogenes the protein can be guided to a genomic locus in a sequence-specific 
manner, using a single guide RNA (sgRNA) which consist of a short targeting crRNA sequence and the scaffold 
tracrRNA sequence. Methods for Cas9-based genome editing have been established in various filamentous fungal 
species  [Reviewed11,12], including the industrially relevant fungi Penicillium rubens13,14 (formerly identified as 
P. chrysogenum15). Cas9 and sgRNA delivery strategies include vector-based expression or genomic integration 
of transcriptional units encoding Cas9 and sgRNA. Alternatively, only Cas9 is expressed and the sgRNA is pro-
vided by a transformation of in vitro transcribed RNA, or both Cas9 and sgRNA are provided as pre-assembled 
ribonucleoprotein complexes (RNPs). The CRISPR/Cas9 genome editing tools established in filamentous fungi 
can edit the genome at a single as well as at multiple locations, and have effectively been applied in industrial 
fungi to improve compound  production11,12.
Beyond genome editing, CRISPR/Cas can be used as a platform for RNA guided DNA–protein interactions, 
and thereby deliver various effector domains to a specific genomic location. By introducing point mutations 
into the two nucleolytic domains, nuclease deficient versions of Cas9, called dead Cas9 (dCas9), were  created16. 
Because dCas9 binds in a sequence-specific manner, but does not cleave DNA, it can be used for transcriptional 
 regulation17,18, epigenome  editing19,20, visualization of specific genomic  loci21 and base  editing22 in various eukary-
otic species. For CRISPR/Cas mediated transcriptional activation (CRISPRa) several activating effector domains 
have been fused to dCas9 [reviewed  in23,24]. The often-used VPR system consists of a three-component complex, 
four copies of the herpes simplex VP16 transactivation domain, the transactivation domain of nuclear factor 
kappa B, and Epstein-Barr virus R transactivator, VP64-p65-Rta,  respectively16. dCas-VPR fusions have been 
successfully employed for upregulation of reporter and/or endogenous genes in mammalian  cells16, in  diploid25 
and  polyploid26 Saccharomyces cerevisiae, Yarrowia lipolytica27, Candida albicans28, and most recently also in the 
filamentous fungus Aspergillus nidulans29.
Here we report on the implementation of a dCas9-VPR-based, genome editing free system for transcriptional 
activation system in the filamentous fungus Penicillium rubens. We successfully utilized the CRISPRa tool to 
activate the cryptic macrophorin BGC, resulting in production of compounds with antimicrobial activity.
Results
Construction of a fungal CRISPRa tool. CRISPR/Cas mediated gene expression activation (CRISPRa) 
requires a catalytically dead CRISPR-associated protein (dCas) fused to an activation domain, as well as a sgRNA 
to guide it to the desired locus. Here, the widely utilized fusion of dCas9 from Streptococcus pyogenes to the 
tripartite activator, VP64-p65-Rta (VPR)16 was selected for activation. For easy implementation of CRISPRa in 
a broad range of filamentous fungi, we constructed an AMA1-based vector for expression of the NLS tagged 
dSpCas9-VPR under the 40S ribosomal protein S8 promoter (p40S) (Fig. 1a). The AMA1 sequence -originally 
isolated from A. nidulans- allows for autonomous vector replication in several filamentous fungal  species30,31, 
and is often employed for Cas9 and sgRNA expression in gene-editing approaches in these  organisms11,13,32,33. 
The AMA1 vector was also used to supply the sgRNA, establishing CRISPRa after a single transformation. The 
sgRNA was expressed from the constitutive gpdA promoter and flanked by hammerhead (HH) and hepatitis 
delta virus (HDV) ribozymes to ensure defined ends for sgRNA processing and optimal functionality (Fig. 1a)34.
Target specificity is determined by the sgRNA, thus by exchanging the sgRNA sequence different genes can 
be targeted for upregulation. To enable convenient and efficient exchange of sgRNA target sequences a sgRNA 
“plug-and-play” module was introduced into the AMA1 shuttle vector to facilitate cloning steps in Escherichia 
coli (Fig. 1a,b). This vector, which is the parent to all sgRNA expressing vectors, is called pLM-AMA18.0-dCas9-
VPR (referred to as pAMA18.0) and also functions as a negative (non-targeting sgRNA) control. The sgRNA 
“plug-and-play” module works as follows; the chimeric sgRNA backbone sequence and the HDV ribozyme are 
already supplied on the AMA1-vector together with a lacZ gene flanked by BsaI restriction sites. The 20 nt spacer 
sequence defining the genomic target is supplied on a separate dsDNA molecule, together with the hammerhead 
ribozyme (HH) which includes the necessary 6 bp inverted repeat of the 5′-end of the spacer to complete the 
HH cleavage site. This dsDNA molecule can simply be created by PCR using two overlapping oligonucleotides 
(Fig. 1b) or alternatively ordered as chemically synthetized dsDNA. The fragment can then be inserted into 
pAMA18.0 using the Golden Gate cloning and the BsaI restriction  sites35. As this removes the lacZ gene, posi-
tive bacterial clones can easily be detected with blue-white screening. After positive sequence verification and 
vector extraction, the created CRISPRa vector can be introduced into the filamentous fungi of choice (Fig. 1b).
Proof of principle: activating penDE‑CP_DsRed. In order to test if expression of dCas9-VPR and the 
sgRNA from the CRISPRa vector could activate transcription of a silent gene, we targeted dCas9-VPR to the 
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penDE core promoter (penDE-CP). The 200 bp long penDE-CP has previously been shown to be functional, but 
insufficient to drive expression on its  own36. For easy visualization of CRISPR based transcriptional activation, 
the penDE-CP was set to drive DsRed-T1-SKL, a red fluorescent reporter gene with peroxisomal targeting signal 
(Fig. 1c). The penDE-CP_DsRed reporter unit was integrated into the penicillin-locus of the P. rubens DS68530 
(∆penicillin-BGC), utilizing CRISPR/Cas9 ribonucleoprotein (RNP) facilitated co-transformation13,14 (Supple-
mentary Fig. S1a).
Different pAMA18.0 derived vectors (pAMA18.a-f) expressing sgRNAs targeting loci + 1 to − 118 bp relative 
to the transcription start site (TSS) of the penDE-CP (Fig. 2a, Supplementary Fig. S2a, Supplementary Table S1) 
were transformed into P. rubens DS68530_penDE-CP_DsRed and strains were analyzed using fluorescence 
microscopy (Fig. 2b). Increased fluorescence intensity was seen in strains transcribing penDE-sgRNA_c, _d, 
and _e but not in strains transcribing penDE-sgRNA_a, _b and _f. The DS68530_penDE-CP_DsRed strain car-
rying the pAMA18.0 negative control vector which did not express any sgRNA, showed only a minimal amount 
of fluorescence. DsRed expression was also evaluated using qPCR, showing the most efficient activation for 
penDE-sgRNA_c (Fig. 2c). These results confirm that activation of DsRed expression was CRISPRa dependent.
To assess the performance of the different sgRNA target sequences, the BioLector microbioreactor system was 
used with online monitoring of scattered light (biomass) and red fluorescence intensity (Fig. 2d, Supplementary 
Figure 1.  Overview of the programmable CRISPR/Cas-based transcriptional activation system implemented in 
P. rubens. (a) Schematic representation of the pAMA18.X-vector encoding the components of the CRISPR/Cas 
activation system, namely the dCas9-VPR and the ribozyme self-cleaved sgRNA. pAMA18.0 is the parent vector 
of all sgRNA containing vectors and contains the sgRNA ”plug-and-play” module which is highlighted. (b) 
Diagram depicting the cloning strategy for insertion of the PCR amplified sgRNA into pAMA18.0. (c) CRISPRa 
proof of principle. In the control strain carrying pAMA18.0 no sgRNAs are transcribed, so while dCas9-VPR 
is present it is not targeted to a specific locus and no transcriptional activation occurs. Correct targeting of the 
dCas9-VPR complex to the silent penDE-CP is leading to DsRed fluorescent protein expression and hence 
increased fluorescence. In the same fashion when dCas9-VPR is targeted to a promoter driving a gene of 
interest, this results in product formation. When the targeted promoter drives a transcriptional regulator this 
can result in activation/repression of multiple other genes, including entire BGCs.
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Fig. S3). The strength of DsRed activation by different sgRNAs was determined relative to biomass to avoid 
variance caused by small differences in growth. During the time interval of 0–40 h, DsRed/biomass values in 
CRISPRa strains were measured and compared to negative control strain carrying pAMA18.0 and the back-
ground fluorescence of the DS68530 parental strain. The pAMA18.c carrying strain showed the highest level 
of relative fluorescence and thus provided the most efficient activation compared to the non-sgRNA negative 
control (Fig. 2d). All other CRISPRa strains show activation of penDE-CP_DsRed, with weakest activation in 
strains carrying pAMA18.a and pAMA18.b vectors.
CRISPRa‑based activation of the transcriptionally silent macrophorin gene cluster. Meroter-
penoids represent a large family of natural compounds with diverse biological activities, such as the antimicro-
bial yanuthones found in Aspergillus niger37,38. Highly identical clusters have been found in Penicillium  species39. 
These Penicillium BGCs contain an additional gene (macJ), which was shown in Penicillium terreste to encode a 
terpene cyclase responsible for cyclization of linear yanuthones leading to production of diverse macrophorin 
 analogs39. The putative P. rubens macrophorin BGC consists of 11 biosynthetic genes, namely macA-J and macR 
as a transcriptional regulator of the cluster (Fig. 3a,b).
Sequence alignment of the provisional sequence of P. rubens macR (Pc16g00410) to the P. terrestre LM2 macR 
coding sequence (MF989995.1) shows that the P. rubens sequence is predicted to have an additional intron leading 
to a premature stop codon. Without this intron, the P. rubens macR mRNA should produce a full-length product, 
similarly to P. terrestre LM2 macR. To test if macR codes for a functional protein we performed promoter replace-
ment in P. rubens DS68530, substituting the promoter region of macR with the promoter of the pcbC (isopenicillin 
N synthase) gene (Supplementary Fig. S1b), creating strain macR:OE. The resulting increase in macR transcrip-
tion (Fig. 3c) led to the activation of the cryptic BGC (Fig. 3d,e) and the production of macrophorins (Fig. 3f,g, 
Supplementary Table S2). We therefore conclude that P. rubens macR encodes for a functional transcription factor 
and that increased expression of macR leads to activation of the entire associated BGC. Moreover, activation of 
this BGC leads to production of macrophorin-like compounds (Supplementary Table S2).
Figure 2.  CRISPRa (dCas9-VPR) based activation of penDE-CP_DsRed. (a) Schematic representation of the 
penDE-CP upstream DsRed. The transcription start site (TSS) is indicated as a black arrow, short lines with 
letters indicate targeting sites of the sgRNAs. (b) Confocal fluorescence microscopy imaging of DsRed targeting 
CRISPRa strains and controls with no-sgRNA (AMA18.0) and without the penDE-CP_DsRed transcription 
unit (DS68530). Strains were grown for 5 days in liquid SMP media. Scale bars represent 50 μm. (c) qPCR 
analysis showing expression levels of DsRed in CRISPRa strains relative to strain carrying pAMA18.0 no-sgRNA 
negative control (dotted line) after 5 days of growth in SMP. (d) Development of DsRed/biomass over time 
during time window of 0–40 h cultivation in the BioLector system. Data were obtained from 3 separate 
experiments, each consisting of 2–3 biological replicates; error bars show the standard deviation.
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Sanger sequencing data of cDNA obtained from the macR:OE strain showed 2 introns in P. rubens macR 
mRNA and no pre-mature stop codon, in line with the coding sequence of macR of P. terrestre (MF989995.1) 
and the homologous yanR (ASPNIDRAFT_44961) of A. niger. It therefore seems likely that the third intron in 
the provisional P. rubens macR sequence is wrongly predicted, and P. rubens is capable of producing, not only 
functional, but also full-length MacR. Additionally, a mutation (cDNA 2611C > T, P776S) mutation was identified 
in the ORF of macR. The effect of this mutation was not further investigated as macR remained capable of tran-
scriptional activation. The sequence of P. rubens DS68530 macR cDNA can be found in Supplementary Note S1.
Figure 3.  CRISPRa activation of the macrophorin BGC. (a) Schematic representation of the macR promoter 
region. The location of the putative transcription start site (TSS) is indicated as a black arrow, short lines 
with number indicate sgRNAs targeting sites. (b) Schematic representation of the Macrophorin BGC. qPCR 
analysis showing expression of macR (c) macA (d) and macJ (e) in the CRISPRa and macR:OE strains, relative 
to the strain carrying the pAMA18.0 vector (non-target control) after 5 days of growth in SMP medium. 
Error bars indicate the standard error of the mean of three biological replicates with two technical duplicates, 
and (*) indicates significant up-regulation (Student’s-test p-value < 0.05). (f) LC–MS UV–VIS chromatogram 
(λ = 700 nm) of hyphae extracts of CRISPRa and macR:OE strains representing macrophorin A (1), 
macrophorin D (2) and 4′-oxomacrophorin D (3). (g) LC–MS analysis of Macrophorin related compounds in 
hyphae extracts of CRISPRa and macR:OE strains. Error bars indicate the standard error of the mean of three 
biological replicates with two technical duplicates. (h) Bioassay to detect (macrophorin related) antimicrobial 
activity against Micrococcus luteus in the supernatant of indicated strains grown for 5 days in liquid SMP 
medium. The supernatant was concentrated 10-times and 100 μl was loaded in a well in top agar containing M. 
luteus at  OD600 = 0.0125. Scale bar represents 10 mm.
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Since the P. rubens macrophorin BGC is silent under our growth conditions (Secondary Metabolite Producing 
[SMP] medium, 25 °C)40,41, it was selected for activation by CRISPRa. As no TSS is known for macR, 20 sgRNAs 
(MacR-sgRNA_1-20) were designed to target the entire 547 bp long, native promoter (Fig. 3a, Supplementary 
Table S1, Supplementary Fig. S2b). The macR targeting CRISPRa strains and the macR:OE positive control, were 
grown on SMP-agar for 10 days after which secondary metabolites were extracted from representative agar plugs, 
and analyzed by LC–MS (Supplementary Table S3). As expected, no macrophorin production was observed in 
the strain carrying the pAMA18.0 negative control with no sgRNA insert. Strains expressing MacR-sgRNA_4 and 
MacR-sgRNA_5 showed production of compounds with masses corresponding to macrophorin A (361.24 m/z 
[M + H]+), macrophorin D (505.28 m/z [M + H]+) and 4′-oxomacrophorin D (503.26 m/z [M + H]+) (Supple-
mentary Table S2). None of the other CRISPRa strains exhibited macrophorin production.
Fungal strains carrying vector pAMA18.3–6 and pAMA18.0 (no sgRNA control) were further investigated 
by qPCR (Fig. 3c-e) and metabolite profiling (Fig. 3f,g). Strains expressing MacR-sgRNA_4 and sgRNA_5 were 
selected as these sgRNAs showed activated macrophorin production (Supplementary Table S3). Although strains 
carrying MacR-sgRNA_3 and sgRNA_6 did not show macrophorin production these strains were also investi-
gated further, as these sgRNAs target the macR promoter region in close proximity to the successfully activat-
ing MacR-sgRNA_4 and sgRNA_5, but on the opposite strand of the DNA. As expected, strains carrying the 
pAMA18.4 or pAMA18.5 CRISPRa vector showed an increase in macR expression compared to the pAMA18.0 
control, further confirming CRISPRa dependent transcriptional activation (Fig. 3c). The increase in macR expres-
sion resulted in transcriptional activation of the macrophorin BGC as exemplified by increased levels of macA 
(polyketide synthase) (Fig. 3d) and macJ (proposed terpene  cyclase39) mRNA (Fig. 3e), that respectively encode 
the first and last enzymes in the macrophorin biosynthesis  pathway39.
In the strain carrying the pAMA18.4 vector, levels of transcriptional activation were comparable to those in 
the positive control macR:OE while strain carrying vector pAMA18.5 showed a ~ threefold lower transcription 
compared to this control, for all genes investigated (Fig. 3c-e). No increased expression of macR, macA or macJ 
was observed for the strain carrying pAMA18.3. In the strain carrying vector pAMA18.6, a slight upregulation 
of macR was observed but this did not result in induction of macA and macJ (Fig. 3c-e). In line with this, the 
strain carrying pAMA18.5 produced lower amounts of the examined macrophorin related metabolites compared 
to the strain with pAMA18.4 (Fig. 3f,g). However, while qPCR analysis showed similar mRNA levels between 
the macR:OE and pAMA18.4 strains, compound production for macrophorin A and 4′-oxomacrophorin D was 
lower in AMA18.4 compared to the macR:OE strain, reaching 15% and 13% respectively. Strain AMA18.4 reached 
highest production for macrophorin D at ~ 38% of the ion intensity measured in macR:OE.
As the related yanuthones produced by A. niger display antimicrobial activity against gram positive  bacteria42, 
we analyzed the activity of our macrophorin producing Penicillium strains against Micrococcus luteus using the 
agar diffusion method. The transformed parent strain P. rubens DS68530 does not contain the penicillin BGC, 
and consequently does not produce compounds inhibiting the growth of M. luteus. We observed a clearance 
zone around concentrated supernatant from the macR:OE strain grown for 5 days in SMP medium, and to a 
lesser extent also around that of the AMA18.4 strain, but not that of the control (AMA18.0) or the AMA18.5 
strain (Fig. 3h). This indicates that the macrophorins produced by P. rubens are indeed bioactive against Gram-
positive bacteria, and CRISPRa dependent activation of the BGC is sufficient to induce antimicrobial activity.
Interestingly, we observed a dark brownish pigmentation of the hyphae of the macR:OE strain after 5 days of 
cultivation on R-agar and SMP-agar as well as on day 1 in SMP liquid medium. The strain carrying the CRISPRa 
vector pAMA18.4 displayed a milder coloration compared to the colorless hyphae of the parent strain (Fig. 4). 
Color formation in these macR over-expression strains was not investigated further.
Discussion
In this work, we report the application of dCas9-VPR based CRISPRa in the ascomycetous filamentous fungus 
Penicillium rubens. While Penicillium is acclaimed for its production of ß-lactam antibiotics, it harbors many 
more BGCs of which a substantial portion remain  uncharacterized43. CRISPRa systems have been established 
in many model organisms as an ideal technology for transcriptional regulation and could aid in activating these 
often silent BGCs to facilitate characterization.
In our approach dCas9-VPR and the sgRNA are episomally encoded on the same AMA1-based vector, hence 
a single transformation with a single vector is enough to establish CRISPR-based transcriptional activation in 
Penicillium, without the need for genome engineering of the host organism. Moreover, because AMA1 supports 
autonomous vector replication in several filamentous fungal  species30,31, and as we use established fungal promot-
ers, terminators, and ribozyme based sgRNA processing, we expect the vector to be transferable to other fungal 
species. The sgRNA “plug-and-play” module of our CRISPRa vector combines Golden Gate cloning approach 
with blue/white screening. This allows for convenient cloning of new sgRNAs into the vector, reducing experi-
mental time. This is especially important since general criteria for successful sgRNA design are difficult to define, 
and empiric testing of sgRNAs for each promoter region of interest remains necessary. Due to the ease of cloning 
our AMA1 vector, this CRISPRa technology could potentially be implemented in connection with larger scale 
fungal protoplast transformations using microtiter  plates44, for example in combination with deploying multiple, 
separate sgRNA processing vectors in one  transformation45.
To assess the CRISPRa vector for activation of transcriptionally silent promoter activation, we integrated 
a penDE core promoter driven DsRed gene into the penicillin-locus of P. rubens DS68530 (∆penicillin-BGC). 
This penDE-CP was selected because it has been reported previously to be insufficient to express the fluores-
cent reporter on its own, instead depending on the presence of a synthetic transcription  factor36. Fluorescence 
microscopy showed a clear increase in fluorescence with 3 out of 6 sgRNAs tested, compared to a non-sgRNA 
expressing control (Fig. 2b). Quantification of fluorescence using a BioLector microbioreactor showed increased 
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fluorescence for 6 out of 6 sgRNA used, showing weak activation for penDE-sgRNA_a and penDE-sgRNA_b 
sgRNAs, and, in line with fluorescence microscopy results, penDE-sgRNA_c standing out as the most efficient 
activator (Fig. 2d). The discrepancy between fluorescence microscopy and the BioLector results could possibly 
be explained by a higher sensitivity of the BioLector, different cultivation method and time points (day 5 of 
shake-flask cultures for microscopy, average fluorescent during the first 40 h for the BioLector cultivations).
In A. niger, Roux and co-workers observed that dCas9-VPR mediated activation of a mCherry fluorescent 
reporter fused to the transcriptionally silent Parastagonospora nodorum elcA promoter was stronger with sgR-
NAs targeting closer to the start codon, in a window of 162–342 bp upstream of the ATG 29. We target a region 
106–170 bp upstream the start codon ATG (32–96 bp upstream the TSS) and observe the highest activation with 
penDE-sgRNA_c targeting 129 bp upstream the ATG, and the least with penDE-sgRNA_a and _b (not detectable 
by microcopy) targeting closer to the start codon. We thus do not see the same trend—stronger CRISPRa for 
sgRNAs targeting closer to the start codon—however we already target a window closer to the ATG compared 
to Roux et al.29. This exemplifies that it remains difficult to define an optimal targeting conditions, and ideally 
several sgRNAs should be tested when establishing CRISPRa for a new promoter. In line with what previously 
was reported for S. cerevisiae, we did not observe an effect on CRISPRa efficiency when targeting the plus or 
minus  strand46.
To show our CRISPRa system can upregulate an entire silent BGC in P. rubens and induce metabolite produc-
tion, we targeted the macR transcription factor of the endogenous macrophorin biosynthesis cluster. Macrophor-
ins are a member of the meroterpenoids, a family of natural compounds which also include, for example, the 
antimicrobial yanuthones produced by A. niger37,38. Homologous macrophorin BGC have been identified in Peni-
cillium species, and P. terreste has been shown to produce macrophorins, through the cyclization of  yanuthones39. 
Out of the 20 sgRNAs tested, two resulted in transcriptional activation of the Macrophorin BGC (through the 
activation of transcriptional factor macR) (Fig. 3c,d) and secondary metabolite production (Fig. 3f,g). Although it 
is impossible to distinguish macrophorins and yanuthones with the method used as they have the same molecu-
lar formula, activation of the macJ terpene cyclase should lead to cyclic  macrophorins39. Additionally we could 
show that the supernatant of the CRISPRa activated strain grown five days in SMP media exhibited antimicrobial 
activity against the Gram-positive bacterium M. luteus (Fig. 3h). This clearly shows that our dCas9-VPR vector 
is capable of awakening silent BGCs in Penicillium and that the method can aid in product identification and 
characterization. It should be noted that exchanging the native macR promoter with the pcbC promoter resulted 
in higher compound production (Fig. 3g). It might therefore be beneficial to perform promoter exchange for high 
level production of interesting compounds identified using the CRISPRa technology. A possible explanation for 
why a larger proportion of the sgRNAs targeting penDE-CP (6/6) lead to transcriptional activation compared to 
macR (2/20) may be that the CP is free from most of its native regulatory elements, reducing chances of interfer-
ence with the binding of the dCas9-VPR regulator. A limiting factor for this way of BGC activation is the need 
to identify a positive regulator for the cluster, which might not always be known. However, bioinformatics tools 
like  antiSMASH47 or  CASSIS48 could aid by identifying candidate regulators.
Recently, dCas12a (previously Cpf1), from Lachnospiraceae bacterium (dLbCas12a) or Acidaminococcus sp. 
(dAsCas12a), has become a popular alternative to dCas9 for gene  regulation49,50. The Cas12a system has been 
popularized due to its ease of multiplexing; dCas12a uses smaller guide RNAs and is capable of processing 
these from a longer precursor CRISPR  RNA51. Recent literature shows processing of 20 crRNA from a single 
precursor and simultaneous upregulation of 10 genes by dCas12a fused to a combination of the p65 activation 
domain together with the heat shock factor 1 in human embryonic kidney (HEK) 293 T cells, exemplifying 
Figure 4.  Dark pigmentation of hyphae due to macR overexpression in Penicillium rubens DS68530 macR:OE 
and in the CRISPRa pAMA18.4 vector carrying strain after 5 days of cultivation on R-agar, compared to 
AMA18.0 strain carrying pAMA18.0 (no sgRNA) negative control.
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the potential of multiplex gene regulation using  dCas12a52. A potential drawback for using dCas12a in fungi 
is the low activity at temperatures below 28 °C, while most fungal species grow optimally at temperatures 
between 25 and 30 °C. However Roux and co-workers recently engineered an temperature tolerant Cas12a mutant 
 (dLbCas12aD156R-VPR), which was successfully employed for CRISPRa mediated gene activation in A. nidulans 
at 25 °C29. While dCas12a is an attractive choice when aiming to upregulate multiple genes simultaneously, for 
single target activation dCas9-VPR is still a good option. We got significant upregulation of an entire BGC using 
a single sgRNA targeting the TF of the BGC. For dLbCas12a based upregulation in A. nidulans (the unmutated 
dLbCas12a grown at 37 °C) multiple crRNAs were required for gene  activation29. Another consideration when 
choosing a system is the different PAM requirement, NGG for (d)Cas9 and TTTN for (d)Cas12a. Depending 
on PAM availability in the genome one or the other could be preferable.
In conclusion we demonstrated that CRISPRa, specifically AMA1 vector-based expression of a dCas9-VPR 
fusion, can be used for the transcriptional activation of silent BGCs in P. rubens. We anticipate that the CRISPRa 
tool presented here can be widely used to awaken cryptic BGC in filamentous fungal species and thereby aid in 
the discovery of novel bioactive secondary metabolites.
Methods
Chemicals, reagents and oligodeoxyribonucleotides. All medium components and chemicals were 
purchased from Sigma-Aldrich (Zwijndrecht, Netherlands) or Merck (Darmstadt, Germany). Oligodeoxyribo-
nucleotide primers (Supplementary Table S4) were obtained from Merck. Enzymes were obtained from Thermo 
Fisher Scientific (Waltham, MA) unless otherwise stated. For design of nucleic acid constructs, in-silico restric-
tion cloning, Gibson Assembly and inspection of Sanger sequencing results, SnapGene (GSL Biotech) was used.
Vector construction. The Golden Gate technology based Modular Cloning (MoClo)  system53 using Type 
IIS BpiI and BsaI restriction enzymes were employed for the construction of all vectors unless stated other-
wise. Constructed vectors with their destination vectors and corresponding PCR fragments or DNA donor vec-
tors can be found in Supplementary Table S5. PCR amplifications were conducted using KAPA HiFi HotStart 
ReadyMix (Roche Diagnostic, Switzerland) according to the instructions of the manufacturer. Internal BsaI, 
BpiI recognition sites were removed for MoClo compatibility.
dCas9-2xNLS-VPR was amplified from two different sources. NLS-VPR was amplified from pAG414GPD-
dCas9-VPR template (AddGene ID # 63801)16 and dCas9-NLS was amplified with adding D10A, D839A, H840A 
and N863A modifications from synthetic spCas9 pYTK036 template, provided as part of the Yeast MoClo Toolkit 
(AddGene ID # 65143)54. DNA sequence of the created dCas9-VPR fusion can be found in Supplementary Note 
S1a.
The HH and HDV ribozyme based “Plug-and-Play” sgRNA transcription unit was amplified in three parts, 
where the gpdA promoter and the trpC terminator together with the HDV self-cleaving sequence were amplified 
from vector pFC334 (AddGene ID # 87846)33 and LacZ alpha gene was amplified from the MoClo ToolKit vec-
tor pICH41308 (AddGene ID # 47998)53. The promoter of 40S ribosomal protein S8 of A. nidulans (AN0465.2, 
referred to as 40S) and the tif35 terminator of P. rubens Pc22g19890, as well as the transcription unit penDE-CP-
DsRed-SKL-TAct, were amplified from pVE2_10 (AddGene ID #154228)36. The terbinafine selection marker 
as Pgpda-ergA-TamdS transcription unit was amplified from  pCP1_4541. The promoter of pcbC (Pc21g21380, 
IPNS) was amplified from pVE2_19 (AddGene ID #154241)36, adding 80 bp flanking regions for homologous 
recombination. The phleomycin selection marker was amplified from pDSM-JAK-10955 providing the PpcbC-
ble-TCYC1 transcription unit, adding 80 bp flanking regions for homologous recombination (Supplementary 
Fig. S1b, Supplementary Table S6).
Our autonomously replicating shuttle vector, carrying the AMA1 sequence, was based on pDSM-JAK-10955 
where the Pgpda-DsRed-SKL-TpenDE transcriptional unit was removed using the BspTI and NotI restriction 
enzymes. The linear vector was treated with the Klenow Fragment and ligated to the circular vector using the 
T4 DNA Ligase according to the instructions of the manufacturer, creating a new AMA1 vector without DsRed 
expression. In order to create the CRISPRa vector, this vector was linearized with BspTI and was assembled by 
Gibson Cloning using PCR fragments G1, G2 G3 (Supplementary Table S5) carrying a terbinafine selection 
marker, dCas9-VPR and the sgRNA transcription unit respectively. CRISPRa vector pLM-AMA18.0 is deposited 
to AddGene under ID #138,945. Parallel with this work a catalytically active spCas9 expressing vector was also 
established (pLM-AMA15.0 AddGene ID #138,944) and utilized for genome editing [manuscript in preparation].
sgRNA target design and cloning. Promoter sequences were analyzed with  CCTop56 for possible 
CRISPR RNA guides with the following limitations: protospacer adjacent motif (PAM): NGG, target sequence 
length 20 bp, core length 12 bp, mismatches taken into account for prediction in core sequence 2, number of 
total mismatches 4 and using P. rubens Wisconsin 54–1255 as the reference genome. Predicted protospacers were 
manually curated for minimizing off-target effects and selecting high  CRISPRater57 scores.
Primers were designed to create 89 bp long dsDNA inserts by PCR, containing the unique 20 nt spacer 
sequence, the hammerhead ribozyme, the 6 bp inverted repeat of the 5′-end of the spacer sequence and the BsaI 
type II restriction enzyme recognition sites.
For cloning the inserts into the vector pAMA18.0 a modified MoClo  protocol53 was used, using FastDigest 
BsaI (Thermo Fisher Scientific, Waltham, MA) restriction enzyme with an initial 10 min digestion, 50 cycles of 
digestion and ligation (37 °C for 2 min, 16 °C for 5 min), followed by a final digestion step and a heat inactiva-
tion step. Correctly assembled vectors were identified with blue-white screening and confirmed by sequencing. 
After positive sequence verification and vector extraction, the created pAMA18.X (where X stands for the sgRNA 
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ID) CRISPRa vector was introduced into the fungal strain of choice (DS68530_penDE-CP_DsRed or DS68530) 
creating the CRISPRa fungal strain AMA18.X (Fig. 1b, Supplementary Table S6).
Fungal strains and transformation. P. rubens strain  DS6853040 (∆penicillin-BGC, ∆hdfA, derived from 
DS17690) was kindly provided by Centrient Pharmaceuticals (former DSM Sinochem Pharmaceuticals, Neth-
erlands). Protoplasts of P. rubens were obtained 48 h post spore seeding in YGG medium and transformed using 
the methods and media as described  previously14.
Mycelium was collected by centrifugation at 4000×g for 8 min at 4 °C. The pellet was resuspended in 50 ml KC 
solution (60 g/l KCl; 2 g/l citric acid; pH set to 6.2). After a second round of centrifugation, the pellet was resus-
pended in 18 ml KC solution and moved to sterile 100 ml shake flask. The mycelium solution was supplemented 
with 25 mg/ml Glucanex Lysing Enzyme from Trichoderma harzianum (Sigma-Aldrich) and incubated at 25 °C 
and 120 RPM for 90 min. Successful protoplast formation was confirmed by microscopy. Protoplast solution 
was moved to a sterile falcon tube and was kept on ice when possible. Protoplast were diluted to 50 ml using 
KC buffer and pelleted by centrifugation at 2770×g for 5 min at 4 °C (same settings were used in all subsequent 
centrifugation steps). Protoplast pellets were resuspended in 25 ml KC buffer followed by addition of 25 ml STC 
buffer (219 g/l sorbitol, 5.5 g/l  CaCl2, 10 mM Tris–HCl pH 7.5; pH set to 7.5 8.0). After centrifugation, pelleted 
protoplasts were resuspended in 50 ml STC and counted by microscopy using a counting chamber. After cen-
trifugation protoplasts were resuspended in STC to obtain 2 × 107 protoplasts/ml (approximately 1–5 ml). These 
protoplasts were used fresh, or stored at − 80 °C in 10% (w/v) PVP-40 (Polyvinylpyrrolidone, Sigma-Aldrich) 
dissolved in STC as a cryopreservation buffer.
Protoplasts were transformed using PEG-mediated  transformation14. In short, 200 μl protoplast solution 
(~ 2 × 107 protoplasts/ml) was added to a sterile 12-ml Greiner tube on ice, and were mixed with 1–8 μg DNA 
(in maximum 50 μl) and 200 μl 20% PEG-4000 solution (33 ml 60% PEG-4000; 67 ml STC buffer; 109.5 g 
sorbitol; 5 ml 1 M TRIS–HCl butter pH 7.5; in final volume of 250 ml). Protoplasts were incubated on ice for 
30 min. Tubes were supplemented with 1.5 ml 60% PEG-4000 solution (60 g PEG-4000 dissolved in 40 ml  H2O 
by heating in a microwave, 1.0 ml 1 M Tris–HCl pH 7.5; 5.0 ml 1 M  CaCl2 in a total volume of 100 ml) and were 
homogenized completely by rotating the tube for 2 min. The tubes were placed in a 25 °C incubator for 25 min. 
1.2 M sorbitol was added to a total of 11 ml, and protoplasts were pelleted by centrifugation at 2770 × g for 5 min 
at 25 °C. Protoplasts were carefully resuspended in 1 ml 1.2 M sorbitol and 100, 200 and 300 ul was plated on 
solid transformation medium.
When transforming the CRISPRa AMA1 vectors, total DNA did not exceed 1 µg. For Cas9-mediated genome 
editing of macR:OE and penDE-CP_DsRed strains, the appropriate Cas9 RNP mixtures were added. Using 
CRISPR/Cas9 ribonucleoprotein (RNP) facilitated co-transformation13,36, marker free DNA was delivered in 10:1 
molar ratio compared to the fungal marker, not exceeding 8 µg total DNA. Synthetized sgRNAs were prepared 
using MEGAscript T7 Transcription Kit (Thermo Fisher Scientific, Waltham, MA) from PCR generated DNA 
templates, and the Cas9 protein was overexpressed in E. coli T7 Express lysY from pET28a/Cas9-Cys (AddGene 
ID #53,261). For each transformation, separate Cas9 RNP mixtures were formed by mixing 27 μg Cas9 protein 
(up to 15 μl), 4 μl of synthetized sgRNA; 35 μl 2 × STC and 30 μl 10 × Cas9 activity buffer (HEPES 4.76 g/l; KCl 
11.18 g/l; EDTA 0.029 g/l;  MgCl2 × 7  H2O 2.03 g/l; pH set to 7.5; DTT 0.08 g/l).
Media and culture conditions. Solid transformation medium was prepared using SAG solid medium 
(Sucrose 375 g/l: Agar 15 g/l; Glucose Monohydrate 10 g/l) supplemented, in this order, with 4 ml/l Trace Ele-
ment  Solution58, 25.7 ml/l stock solution A; 25.7 ml/l stock solution B and 2.4 ml/l 4 M KOH (where stock 
solution A contained the following: KCl 28.80 g/l;  KH2PO4 60.8 g/l;  NaNO3 240 g/l, at pH 5.5 (adjusted using 
KOH) and stock solution B contained: MgSO4·7H2O at 20.80 g/l). Selection for the terbinafine marker based 
macR:OE cassette and all CRISPRa vector carrying transformants was carried out using 1.1 μg/ml terbinafine 
hydrochloride (Sigma-Aldrich) in the solid transformation medium. Terbinafine was supplemented in all media 
of consecutive experiments, whereas selection for penDE-CP_DsRed and PpcbC-ble-tCYC 1 co-transformation 
was done using medium containing 50 μg/ml phleomycin (Invivogen, San Diego, CA). For each strain, 2 sepa-
rate transformant colonies were selected as replicates and re-streaked individually on solid R-agar (see below) 
medium and cultivated for 7 days on 25 °C to produce spores, which were immobilized on lyophilized rice grains 
and used for further experiments. Schematic representation of engineering DS68530_penDE-CP_DsRed and 
macR:OE control strains, using CRISPR/Cas9 mediated homologous recombination-based co-transformation 
into DS68530, is shown on Supplementary Figure S1. For each created strain, transformed DNA is listed in Sup-
plementary Table S6.
For shake-flask liquid cultures, spores immobilized on lyophilized rice grains (0.2 × 106–2 × 106 spores/ml) 
were precultured for 24 h in YGG  medium59 before inoculation (1:7.5) into 30 ml Secondary Metabolite Produc-
ing (SMP)  medium59 (Penicillin Producing Medium-PPM-without supplemented phenoxyacetic acid or pheny-
lacetic acid), supplemented with 1.1 μg/ml terbinafine. Cultures were grown at 25 °C in a rotary incubator at 200 
RPM for 5 days, after which mycelium was collected for total RNA extraction as well as extraction of secondary 
metabolites by vacuum filtration over filter paper. Solid R-agar  medium58 was used for sporulation, SMP-agar 
(SMP medium supplemented with 15 g/l agar–agar) was used for cultivation, and for secondary metabolite 
extraction. All solid agar cultures were incubated at 25 °C.
Total RNA extraction and cDNA synthesis. Total RNA was extracted from mycelium collected from 
cultures grown in SMP for 5 days at 25 °C. Wet biomass (~ 200 mg) was added to a screw cap tube contain-
ing 900  μl Trizol reagent (Thermo Fisher Scientific, Waltham, MA), 125  μl chloroform and glass beads (ø 
0.75–1 mm, 500-600 mg). The samples were stored at -80 °C until RNA isolation. The mycelium was disrupted 
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using the FastPrep FP120 system (Qbiogene, Carlsbad, CA), followed by total RNA isolation using the phenol–
chloroform extraction method. In short, after cell disruption phases were separated by centrifugation (10 min 
at 14,000×g, the upper phase was transferred to a new tube, followed by a chloroform extraction step (phase 
separation: 5 min at 12,000×g). RNA was precipitated by the addition of 1 volume isopropanol and incubated 
on ice for at least 10 min, followed by centrifugation (10 min at 12,000×g). Finally, the RNA was resuspended in 
milliQ  H2O. DNAse treatment was done using the TURBO DNA-free Kit (Thermo Fisher Scientific, Waltham, 
MA), and the RNA concentration was determined using Nanodrop. cDNA was synthesized using RevertAid H 
Minus First Strand cDNA synthesis kit (Thermo Fisher Scientific, Waltham, MA) according to the manufac-
turer’s instructions for highly structured mRNAs using oligo (dT)18 primers and 1 μg of total RNA as template 
in a 20 μl reaction.
qPCR analysis. Primers used to analyze expression DsRed, macR, macA and macJ can be found in Supple-
mentary Table S7. Primers were, when possible, designed to overlap an intron–exon junction to avoid amplifica-
tion on gDNA. The γ-actin gene (Pc20g11630) was used as a control for normalization. The 25 μl qPCR reaction 
contained 4 μl of a 20 × diluted cDNA synthesis reaction, 0.6 μM each of forward and reverse primer, and 12.5 μl 
SensiMix SYBR Hi-ROX master mix (Meridian Bioscience, Memphis, TN). Expression levels were determined 
with a MiniOpticon system (Bio-Rad, Hercules, CA) using the Bio-Rad CFX manager software, the threshold 
cycle (Ct) values were determined automatically by regression. Thermocycler conditions were as follows: 95 °C 
for 10 min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 30 s, and 72 °C for 30 s. Thereafter, a melting curve 
was generated to determine the specificity of the qPCRs.
LC–MS sample preparation. For secondary metabolite analysis samples were taken from vacuum filtered 
mycelium or from solid SMP-agar medium as 3 × 1 cm diameter plugs. The plugs were transferred to a 4.0 ml 
glass vial and 1 ml acetone supplemented with 4 μl n-Dodecyl-β-D-maltoside (DDM) (10 mg/ml in methanol) 
was added as internal standard. The plugs were extracted ultrasonically for 60 min, after which the extracts were 
transferred to a clean vial and dried under a nitrogen stream at 25 °C. Dried extracts were resuspended in 200 μl 
methanol:milliQ-H2O (1:1) and filtered via a 0.2 μm PTFE syringe filter before the used for LC–MS analysis.
LC–MS metabolite analysis. Metabolite analysis was performed using an Accella1250 UHPLC system 
coupled to a benchtop ESI–MS Orbitrap Exactive (Thermo Fisher Scientific, Waltham, MA) mass-spectrometer. 
A sample of 5 μl was injected onto a Waters Acquity CSH C18 UPLC (UHPLC) column (150 × 2.1 mm, 1.7 μm 
particle size) operating at 40 °C with a flow rate of 300 μl/min. Separation of the compounds was achieved by 
using a water-acetonitrile gradient system starting from 90% of solvent A (milliQ-water) and 5% solvent B 
(100% acetonitrile). 5% of solvent C (2% formic acid) was continuously added to maintain a final concentra-
tion of 0.1% of formic acid in the mobile phase. After 5 min of initial isocratic flow, the first linear gradient 
reached 60% of B at 30 min, and the second 95% of B at 35 min. A purge step for 10 min at 90% of B was fol-
lowed by column equilibration for 15 min at the initial conditions. The column eluent was directed to a HESI-II 
ion source attached to the Exactive Orbitrap mass spectrometer operating at the scan range (m/z 80–1600 Da) 
and alternating between positive/negative polarity modes for each scan. LC–MS data were analyzed using the 
Thermo Scientific Xcalibur 2.2 processing software by applying the Genesis algorithm for peak detection and 
manual integration on the sum of the whole spectra of selected ions. The extracted ion counts of investigated 
compounds were normalized to the DDM internal standard and represented relative to the average detected 
values from the MacR:OE strain replicates. In addition to LC–MS only UV–VIS absorption was monitored at 
220, 354 and 700 nm. Ions corresponding to the [M + H]+ pseudo molecular ions of the final steps of the mac-
rophorin biosynthesis pathway (Macrophorin A, macrophorin D and 4′-oxomacrophorin D) were identified in 
chromatographic peaks (1), (2) and (3) respectively and were selected for further analysis. The peaks recorded 
by each channel for (1), (2) and (3) in match in retention time. The chromatogram recorded at 700 nm showed 
the best signal-to-noise ratio. (Fig. 3f, Supplementary Fig. S4). Due to the necessity of adding an in-line UV–VIS 
detector between the MS and the column to generate UV–VIS chromatograms, small discrepancy in Rt between 
different datasets was observed.
Biolector. Spores (immobilized on 20 rice grains) were used to inoculate 10  ml SMP and cultures were 
incubated for 48 h in a rotary incubator at 200 rpm and 25 °C. For BioLector analysis and analysis of growth in 
FlowerPlate (MTP-48-B) wells, this pre-grown mycelium was diluted 8 times in fresh SMP, supplemented with 
1.1 μg/ml terbinafine (except for parent strain DS68530). The 1 ml cultures were grown in the BioLector micro-
bioreactor system (M2Plabs, Baesweiler, Germany), shaking at 800 rpm at 25 °C. In the BioLector, biomass was 
measured via scattered light at 620 nm excitation without an emission filter. The fluorescence of DsRed-SKL 
was measured every 30 min with “DsRed I” 550 nm (bandpass: 10 nm) excitation filter and 580 nm (bandpass: 
10 nm) emission filter. Data were obtained from 3 separate experiments, each consisting of 2–3 biological repli-
cates. The data obtained from the BioLector experiments were analyzed and presented using the TIBCO Spotfire 
Software (TIBCO Software Inc., Palo Alto, CA).
Fluorescence microscopy. For visualization of DsRed-SKL fluorescent protein, liquid shake-flask cultures 
were cultivated for 5 days in SMP, and mycelium was collected and re-suspended in phosphate-buffered saline 
(58 mM  Na2HPO4; 17 mM  NaH2PO4; 68 mM NaCl, pH 7.3). Confocal imaging was performed on a Carl Zeiss 
LSM800 confocal microscope using 20 × objective and ZEN 2009 software (Carl Zeiss, Oberkochen, Germany). 
The DsRed signal was visualized by excitation with a 543 nm helium neon laser (Lasos Lasertechnik, Jena, Ger-
many), and emission was detected using a 565 to 615 nm band-pass emission  filter60.
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Bio‑assay. Macrophorin producing strains were tested for antimicrobial activity against Micrococcus luteus 
as follows: Supernatant of P. rubens strains carrying either the pAMA18.0, pAMA18.4, pAMA18.5 vector and 
the macR:OE strain was collected after 5 days of growth in liquid SMP medium and concentrated 10 × in an 
Eppendorf Concentrator Plus (30 °C, vacuum for aqua solutions setting). An overlay of soft LA-agar (1%) inocu-
lated with M. luteus to an OD600 of 0.125 was poured on top of an agar (1%) bottom layer with Oxford Towers 
(8 × 10 mm) spaced out evenly. The Oxford Towers were removed aseptically and 100 μl of the 10 × concentrated 
supernatant was loaded in the resulting wells as indicated. The plate was incubated at 30 °C for 24 h before imag-
ing. The experiment was performed in triplicate.
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